© Drug Hunter Inc. 2018-2023
Home > MLT-985
allosteric MALT1 protease (paracaspase) inh.
oral QD act. in xenograft; on-target pathology
from 1M cmpd biochem. HTS and opt.
J. Med. Chem., Nov. 20, 2020
Novartis, Basel, CH
MLT-985 (Novartis allosteric MALT1 protease (paracaspase) inhibitor)
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
Molecules of the Month
Molecule of the Year